From the Division of Rheumatology, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alta.; the School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands
Can J Surg. 2024 Mar 7;67(2):E108-E111. doi: 10.1503/cjs.007123. Print 2024 Jan-Feb.
SummaryThe House of Commons Standing Committee on Health proposed in 2022 to start a national registry for breast implants. Why, and what requirements are needed, will be outlined. Breast implant products are not always in compliance with international norms and standards, and several scandals have occurred because of industry fraud. To trace which patients have defective breast implants, a good registry is an absolute must. Furthermore, some diseases, such as lymphomas, autoimmune diseases, and so-called breast implant illness, are believed to be associated with breast implants. An accurate estimation of how often these diseases occur in patients with breast implants is lacking. A registry in which not only surgical data but also patient-reported outcome measurements are recorded will result in a better understanding of patient outcomes and device performance. The registry should not be a voluntary ("opt-in") registry but a mandatory ("opt-out") registry, in which only the patient (and not the surgeon) has the choice whether to participate.
2022 年,加拿大下议院健康常设委员会提议建立全国性的乳房植入物登记处。本文将概述建立该登记处的原因和所需的要求。乳房植入产品并非总是符合国际规范和标准,并且由于行业欺诈已经发生了几起丑闻。为了追踪哪些患者有缺陷的乳房植入物,一个好的登记处是绝对必要的。此外,一些疾病,如淋巴瘤、自身免疫性疾病和所谓的乳房植入物疾病,被认为与乳房植入物有关。缺乏对乳房植入物患者中这些疾病发生频率的准确估计。一个不仅记录手术数据而且还记录患者报告的结果测量的登记处将导致对患者结局和设备性能的更好理解。该登记处不应该是一个自愿(“选择加入”)的登记处,而应该是一个强制性(“选择退出”)的登记处,只有患者(而不是外科医生)有权选择是否参与。